# Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness

> **NCT06110403** · PHASE1,PHASE2 · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 35 (estimated)

## Conditions studied

- Copd

## Interventions

- **DRUG:** TRIXEO AEROSPHERE

## Key facts

- **NCT ID:** NCT06110403
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-29
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06110403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06110403, "Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06110403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*